Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/171106
Title: Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action
Author: Manchia, Mirko
Vieta i Pascual, Eduard, 1963-
Smeland, Olav B.
Altimus, Cara
Bechdolf, Andreas
Bellivier, Frank
Bergink, Veerle
Fagiolini, Andrea
Geddes, John R.
Hajek, Tomas
Henry, Chantal
Kupka, Ralph
Lagerberg, Trine V.
Licht, Rasmus W.
Martinez-Cengotitabengoa, Monica
Morken, Gunnar
Nielsen, René E.
González-Pinto, Ana
Reif, Andreas
Rietschel, Marcella
Ritter, Phillip
Schulze, Thomas G.
Scott, Jan
Severus, Emanuel
Yildiz, Aysegul
Kessing, Lars Vedel
Bauer, Michael
Goodwin, Guy M.
Andreassen, Ole A.
European College of Neuropsychopharmacology (ECNP) Bipolar Disorders Network
Keywords: Trastorn bipolar
Dades massives
Manic-depressive illness
Big data
Issue Date: Jul-2020
Publisher: Elsevier B.V.
Abstract: Bipolar disorder (BD) is a major healthcare and socio-economic challenge. Despite its substantial burden on society, the research activity in BD is much smaller than its economic impact appears to demand. There is a consensus that the accurate identification of the underlying pathophysiology for BD is fundamental to realize major health benefits through better treatment and preventive regimens. However, to achieve these goals requires coordinated action and innovative approaches to boost the discovery of the neurobiological underpinnings of BD, and rapid translation of research findings into development and testing of better and more specific treatments. To this end, we here propose that only a large-scale coordinated action can be successful in integrating international big-data approaches with real-world clinical interventions. This could be achieved through the creation of a Global Bipolar Disorder Foundation, which could bring government, industry and philanthropy together in common cause. A global initiative for BD research would come at a highly opportune time given the seminal advances promised for our understanding of the genetic and brain basis of the disease and the obvious areas of unmet clinical need. Such an endeavour would embrace the principles of open science and see the strong involvement of user groups and integration of dissemination and public involvement with the research programs. We believe the time is right for a step change in our approach to understanding, treating and even preventing BD effectively.
Note: Reproducció del document publicat a: https://doi.org/10.1016/j.euroneuro.2020.05.006
It is part of: European Neuropsychopharmacology, 2020, vol. 36, p. 121-136
URI: http://hdl.handle.net/2445/171106
Related resource: https://doi.org/10.1016/j.euroneuro.2020.05.006
ISSN: 0924-977X
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
702182.pdf1.3 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons